| Literature DB >> 33195849 |
Mouad Hasni1, Zineb Farahat1, Azar Abdeljelil1, Kamal Marzouki1,2, Mohamed Aoudad1,2, Zakaria Tlemsani1,2, Kawtar Megdiche1, Nabil Ngote3.
Abstract
PURPOSE: To reconstruct a 3D visualization from CT images of COVID-19 patients in order to improve understanding of the disease for better management and follow-up.Entities:
Keywords: ANATOMAGE table; Biomedical engineering; COVID-19; CT; DICOM; Diagnostic; Follow-up; Infectious disease; Management; Monitoring; Pathology; RT-PCR; Radiology; Respiratory system; SARS-CoV-2; Virology
Year: 2020 PMID: 33195849 PMCID: PMC7648513 DOI: 10.1016/j.heliyon.2020.e05453
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Clinical Characteristics of COVID-19 and non-COVID-19 patients.
| COVID-19 (n = 90) | Non-COVID-19 (n = 95) | |
|---|---|---|
| Age (year) | ||
| Mean age | 53 (+/-18) | |
| <20 | 17 (18.8%) | 7 (7.3%) |
| 20-39 | 28 (31.1%) | 21 (22.1) |
| 40-59 | 34 (37.7) | 48 (50.5%) |
| ≥60 | 11 (12.2%) | 19 (20%) |
| Sex | ||
| Male | 53 (58.8%) | 49 (51.5%) |
| Female | 37 (41.1%) | 46 (48.4%) |
| Presence of Fever | ||
| Fever | 75 (83.3%) | 69 (72.6%) |
| No fever | 15 (16.6%) | 26 (27.3%) |
| White blood cell Count | ||
| Elevated | 82 (91.1%) | 63 (66.3%) |
| Normal | 8 (8.8%) | 32 (33.6%) |
| Lymphocyte count | ||
| Normal | 12 (13.3%) | 72 (75.7%) |
| Decreased | 78 (86.6%) | 23 (24.2%) |
| Comorbidities | ||
| Cardiovascular Disease | 18 (20%) | 14 (14.7%) |
| Hypertension | 21 (23.3%) | 11 (11.5%) |
| COPD | 7 (7.7%) | 8 (8.4%) |
| Dibetes | 12 (13.3%) | 9 (9.4%) |
| Chronic liver Disease | 0 (0%) | 0 (0%) |
| Chronic kidney Disease | 2 (2.2%) | 1 (1%) |
| Malignant tumor | 4 (4.4%) | 0 (0%) |
| HIV | 0 (0%) | 0 (0%) |
| Severity | ||
| Mild | 52 (57.7%) | - |
| Medium | 14 (15.5%) | - |
| Severe | 15 (16.3%) | - |
| Critical | 9 (10%) | - |
Figure 1Flowchart of the 3D reconstruction realization.
Figure 2Chest CT slice of patient (A1) with no abnormalities.
Figure 3Image of the 3D reconstruction (A1): no abnormalities suggesting lung injuries related to pneumonia.
Figure 4Chest CT slice of patient (A2) with no abnormalities.
Figure 5Image of the 3D reconstruction (A2): no abnormalities suggesting lung injuries related to pneumonia.
Figure 6Chest CT slice of PCR positive patient (B1) with multilobar images of ground glass opacity (GGO) mainly located in the inferior lobes.
Figure 7Images of the 3D reconstruction of PCR positive patient (B1) lungs showing enlarge injury of both lungs.
Figure 8Chest CT slice of PCR positive patient (B2) showing GGO in right upper lobe and consolidation opacity in the right middle lobes.
Figure 9Image of the 3D reconstruction of PCR positive patient (B2) lungs showing limited injury of right lung and increased density in left middle lobes.
Figure 10Images of the 3D reconstruction of PCR false negative patient (C), showed peripheral, bilateral, and basal predominant distributed areas of ground-glass opacities (outlined in red).
Figure 11Evolution of Covid-19 disease from the day of patient's admission to the day of discharge.